Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value

C1q Binds Phosphatidylserine and Likely Acts as a Multiligand-Bridging Molecule in Apoptotic Cell Recognition

(2014) H. Paidassi et al.   JOURNAL OF IMMUNOLOGY

Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer

(2009) Annelies Debucquoy et al.   JOURNAL OF CLINICAL ONCOLOGY

Intrinsic subtype-associated changes in the plasma proteome in breast cancer

(2009) Harikrishna Nakshatri et al.   Proteomics Clinical Applications

Cancer exploiting complement: a clue or an exception?

(2008) Bruce E Loveland et al.   NATURE IMMUNOLOGY

Modulation of the antitumor immune response by complement

(2008) Maciej M Markiewski et al.   NATURE IMMUNOLOGY

Inhibition of p38 MAPK Suppresses Inflammatory Cytokine Induction by Etoposide, 5-Fluorouracil, and Doxorubicin without Affecting Tumoricidal Activity

(2008) Collin R. Elsea et al.   PLoS One